Click ingredient brand name for product website.
| Code | Product Name | Standardization |
|---|---|---|
| 124 | Alpha Lipoic Acid (80 Mesh) | 99% Alpha Lipoic Acid |
| 1901 | Amla Extract (Emblica officinalis) Saberry® (with Maltodextrin) | 10% ß-Glucogallin |
| 0102 | Artocarpus Lakoocha Extract (Artocarpus lakoocha) Artonox® | 95% Oxyresveratrol |
| 1200 | Bacillus coagulans (Weizmannia coagulans)(MTCC 5856) LactoSpore® | 15 Billion Organisms/g |
| 0327 | Coconut Liquid Endosperm WS (Cocos nucifera)) Cococin® WS | 80% Total Carbohydrates 0.1% Free Amino Acids 0.05% Magnesium 0.5% Potassium |
| 2023 | Tetrahydrocurcuminoids ODN (Curcuma longa) Curcumin C3 Reduct® ODN | 95% Tetrahydrocurcuminoids |
| 0561 | Pomegranate Extract 90% (Punica granatum) | 90% Ellagic Acid |
| 1677 | Pterocarpus Extract 90% (Pterocarpus marsupium) Silbinol® | 90% Pterostilbene |
| 1825 | Rosemary Extract (Rosmarinus officinalis) | 6% Carnosic Acid 1.5% Ursolic Acid 1% Rosmarinic Acid |
| 1820 | Resveratrol (Polygonum cuspidatum) Resvenox® | 95% Resveratrol |
Patents
1. Coconut Liquid Endosperm (Cococin™ ) + Amla Extract (Saberry® )
- US 8,247,003; AU2010326651; EA020368; EP2461786; NZ598630: Protective compositions for dermal papilla cells.
2. Coconut Liquid Endosperm (Cococin™ ) + Amla Extract (Saberry® ) + PeptiSeLect®- Proscalpin™
- US 9,498,423; AU2012203148; CA2872535; EP2695603; HK1193758; IDP000051688; JP6064274; MX355546; MY-168089-A; NZ600307; RU2606752: Synergistic selenopeptide formulations for the protection of dermal papilla cells.
3. Coconut Liquid Endosperm (Cococin™ )
- US 7,300,682: Method of preparation and use of coconut water in mammalian tissue nourishment growth and healthy maintenance.
- EP1341547: Coconut water and its method of preparation.
4. Coleus Forskohlii Oil
- US 6,607,712: Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii.
5. Curcuma Longa Extract (Tetrahydrocurcuminoids CG)
- EP1328263: Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells.
6. Pterocarpus Extract (pTeroWhite® )
- KP1011504: Melanogenesis inhibition by 3, 5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof.
7. Sugarcane Peel Extract (Policosanol)
- US 7,217,546: Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails.
- IN229695: A process for obtaining high purity fatty alcohols.
8. Olepent®
- CA 2975170, EA035128, AU2015381703: Oleanoyl peptide compositions and collagen enhancement.
- US 8,383,594: Peptides modified with triterpenoids and small organic molecules: Synthesis and use in cosmeceuticals.
- US 8,987,212;AU2011265587; JP6176893: Oleanoyl peptide composition and a method of treating skin aging.
- US 10,071,043: Oleanoyl peptide composition and skin hydration.
9. Oletrip®
- US 10,588, 844; RU2733372: Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof.
10. PeptiSeLect®
- US 8,003,614: Novel dipeptides incorporating selenoamino acids with enhanced bioavailability.
- US 8,193,156: Dipeptides incorporating selenoamino acids with enhanced bioavailability- synthesis, pharmaceutical and cosmeceutical applications thereof.
11. Bacillus Ferment Extract (LactoSporin® )
- US 10,966,919; US 9,596,861; US 9,635,862; US 9,681,665; US 9,681,666; AU2014369819; MY-181102-A; AU2017228561; CA2899511; EP2989197; IDP00201506134; JP6918988; JP6126307; KR10-2296051; KR10-2288904; KR10-2288897; KR 10-1770902; NZ711345; PH1-2015-502025; RU2617965; SG11201505628P; ZL201480010615.0: Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof.
- US 10,966, 919: Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856.
12. Bacillus Ferment Extract (LactoSporin® ) + SabiLize®
- US 9,681,666; US 9,635,862; AU2014369819; CA2899511; IDP00201506134; JP6126307; KR10-1770902; NZ711345; PH1-2015-502025; RU2617965; SG11201505628P; ZL201480010615.0: Method of producing partially purified extracellular metabolite products fromBacillus coagulansand biological applications thereof.
13. SabiLize®
- US 8,329,095: Preservative system for cosmetic formulations compositions and methods thereof.
14. OxyResvenox®
- US 7,253,324: Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers.
15. TetraPure®
- US 8,119,696: Treatment of superficial and cutaneous mycoses with a pure form of1,7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione.